| Molecular Targets of Natural Compounds with Anti-Cancer Properties M Kubczak, A Szustka, M Rogalińska International journal of molecular sciences 22 (24), 13659, 2021 | 54 | 2021 |
| Nanoparticles for local delivery of siRNA in lung therapy M Kubczak, S Michlewska, M Bryszewska, A Aigner, M Ionov Advanced Drug Delivery Reviews, 114038, 2021 | 26 | 2021 |
| In Vitro Anticancer Properties of Copper Metallodendrimers M Hołota, J Magiera, S Michlewska, M Kubczak, NS del Olmo, ... Biomolecules 9 (4), 155, 2019 | 24 | 2019 |
| Synthesis and Characterization of FITC Labelled Ruthenium Dendrimer as a Prospective Anticancer Drug S Michlewska, M Kubczak, M Maroto-Díaz, N Sanz del Olmo, P Ortega, ... Biomolecules 9 (9), 411, 2019 | 22 | 2019 |
| Tyrosine-modified linear PEIs for highly efficacious and biocompatible siRNA delivery in vitro and in vivo M Karimov, M Schulz, T Kahl, S Noske, M Kubczak, I Gockel, R Thieme, ... Nanomedicine: Nanotechnology, Biology and Medicine 36, 102403, 2021 | 21 | 2021 |
| Bioactive Compounds and Antiradical Activity of the Rosa canina L. Leaf and Twig Extracts M Kubczak, AB Khassenova, B Skalski, S Michlewska, M Wielanek, ... Agronomy 10 (12), 1897, 2020 | 16 | 2020 |
| Hippophae rhamnoides L. leaf and twig extracts as rich sources of nutrients and bioactive compounds with antioxidant activity M Kubczak, AB Khassenova, B Skalski, S Michlewska, M Wielanek, ... Scientific Reports 12 (1), 1-14, 2022 | 12 | 2022 |
| Unmodified and tyrosine-modified polyethylenimines as potential carriers for siRNA: biophysical characterization and toxicity M Kubczak, S Michlewska, M Karimov, A Ewe, S Noske, A Aigner, ... International journal of pharmaceutics, 121468, 2022 | 11 | 2022 |
| Combined therapy of ruthenium dendrimers and anti-cancer drugs against human leukemic cells S Michlewska, M Maroto, M Hołota, M Kubczak, NS del Olmo, P Ortega, ... Dalton Transactions, 2021 | 11 | 2021 |
| Dose and drug changes in chronic lymphocytic leukemia cell response in vitro: A comparison of standard therapy regimens with two novel cyclin‑dependent kinase inhibitors M Kubczak, A Szustka, JZ Błoński, T Gucký, M Misiewicz, V Krystof, ... Molecular medicine reports 19 (5), 3593-3603, 2019 | 3 | 2019 |
| Ewolucja przeciwciał monoklonalnych w leczeniu chorób nowotworowych M Kubczak, M Rogalińska Postępy Biochemii 62 (4), 518-525, 2016 | 3 | 2016 |
| Evolution of monoclonal antibodies in cancer treatment M Kubczak, M Rogalińska Postepy biochemii 62 (4), 518-525, 2016 | 3 | 2016 |
| Non-food crop Rosa canina L leaf and twig extracts as a source of nutrients and bioactive compounds M Kubczak, AB Khassenova, B Skalski, S Michlewska, M Wielanek, ... bioRxiv, 2020 | | 2020 |
